ArticleAngewandte Chemie (International ed. in English)2026
Trisoxazole Macrolides Potentiate the Microtubule Assembly and Antimitotic Activities of Taxanes.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Mycalolides are marine-derived trisoxazole macrolides that exhibit potent actin-depolymerizing activity and inhibit the proliferation, migration, and invasion of various cancer cells. The C25-C35 side-chain moiety of mycalolides is important for their actin-binding properties; however, the biological function of the C1-C24 trisoxazole macrolactone moiety remains largely unexplored. In this study, using a photoaffinity biotin probe, we identified tubulin as a new, actin-independent target of mycalolide C (MyC). Ultracentrifugation, fluorescence-based tubulin polymerization assays, and transmission electron microscopy of negatively stained microtubules (MTs) demonstrated that MyC and trisoxazole macrolactones exert potent synergistic effects on paclitaxel-induced MT assembly and stabilization. These compounds enhanced the antiproliferative activity of paclitaxel by 4.2- to 6.7-fold in HCT-116 human colon cancer cells but showed little synergy in 3T3-L1 murine fibroblast. Molecular modeling studies suggest that MyC stabilizes the protein-protein interactions between α/β-tubulin heterodimers. Given that the C1-C24 trisoxazole macrolactone moiety and its analogues exhibit little cytotoxicity, our findings may contribute to the development of new lead compounds for MT inhibitors with reduced side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.